Status:
UNKNOWN
Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring
Lead Sponsor:
St. Francis Hospital, New York
Conditions:
New Onset Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk o...
Detailed Description
There is a significant incidence of recurrent AF following initial diagnosis of AF. Inclusion of left atrial (LA) and left atrial appendage (LAA) abnormalities together with risk prediction of CVA us...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Newly diagnosed AF
- Patient or legal guardian is willing and able to provide informed written consent and comply with follow-up visits and testing schedule
Exclusion
- Patient is participating in or plans to participate in any other investigational drug or device clinical trial that has not reached its primary endpoint
- Patient received an organ transplant, or is on a waiting list.
- Patient is not able to follow instructions for remote monitoring 4 Prior history of AF
Key Trial Info
Start Date :
July 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04038944
Start Date
July 17 2019
End Date
September 1 2023
Last Update
July 31 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St Francis Hospital
Roslyn, New York, United States, 11576
2
St. Francis Hospital
Roslyn, New York, United States, 11576